You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

factor Xa inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Anticoagulant-induced Bleeding Trial in Seoul (Factor Xa Inhibitor)

Recruiting
  • Atrial Fibrillation
  • Anticoagulant-induced Bleeding
  • Factor Xa Inhibitor
  • Seoul, Jongno-gu, Korea, Republic of
    Seoul National university Hostpital
Apr 5, 2023

Contrast Agents and Oral Factor Xa Inhibitor Trial in Bursa (computerized tomography)

Completed
  • Contrast Agents and Oral Factor Xa Inhibitor
  • computerized tomography
  • Bursa, Turkey
    Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Oct 27, 2020

Health Care Interventions and Outcomes of Major Bleedings in

Not yet recruiting
  • Major Bleeding
  • None (Observational study)
  • (no location specified)
Nov 17, 2023

Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)

Not yet recruiting
  • Coagulation Disorder
  • (no location specified)
Jul 14, 2022

AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))

Recruiting
  • AORTIC VALVE DISEASES
  • Thromboembolism
  • Rivaroxaban Oral Tablet
  • Vitamin K antagonist(warfarin)
  • Bucheon, Korea, Republic of
  • +8 more
Oct 11, 2022

Urgent Surgery Trial (Andexanet alfa, Usual Care)

Not yet recruiting
  • Urgent Surgery
  • Andexanet alfa
  • Usual Care
  • (no location specified)
Jun 21, 2023

Outcomes in Hospitalised Patients Treated With Ondexxya

Not yet recruiting
  • Hemorrhage
  • Andexanet alfa
  • (no location specified)
Jun 12, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic

Completed
  • Dose Adjustment of Enoxaparin in ICU Patients
  • Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
  • Kfar Saba, Israel
    Meir Medical Center
Jan 23, 2022

Hemophilia Trial (Coagulation Factor VIIa (Recombinant))

Not yet recruiting
  • Hemophilia
  • Coagulation Factor VIIa (Recombinant)
  • (no location specified)
Jan 12, 2023

Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

Not yet recruiting
  • Rheumatoid Arthritis
  • Observation
  • (no location specified)
Oct 8, 2022

Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

Completed
  • Covid19
  • +2 more
  • The effect of LMWH
  • Monitoring frequency of aFXa-levels
  • Stockholm, Sweden
    Södersjukhuset
Feb 24, 2022

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

Completed
  • Arthritis Rheumatoid
  • New York, New York
    Pfizer
Jun 8, 2022

Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

Recruiting
  • Arthritis, Rheumatoid
  • +2 more
    • Aalborg, Denmark
      Department of rheumatology
    Sep 1, 2022

    Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and

    Unknown status
    • Anticoagulation
    • +2 more
    • Estimated anticoagulant level (conversion factor x anti-Xa activity)
    • (no location specified)
    Nov 30, 2020

    Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
    • +3 more
    Jan 18, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII Trial in United Kingdom, United States (Valoctocogene

    Recruiting
    • Hemophilia A With Inhibitor
    • Hemophilia A With Anti Factor VIII
    • Valoctocogene roxaparvovec
    • Los Angeles, California
    • +4 more
    Aug 2, 2022

    Anti-citrullinated Protein Antibody Status on Treatment Response

    Completed
    • Rheumatoid Arthritis
    • Non-Interventional
    • Canberra City, Australia
      (unnamed)
    Feb 22, 2022

    Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency Trial in China (SS109)

    Recruiting
    • Hemophilia A With Inhibitor
    • +2 more
    • SS109
    • Hefei, Anhui, China
    • +9 more
    Jan 12, 2023

    Hemophilia A Trial in Metairie, New Orleans (Factor IX)

    Recruiting
    • Hemophilia A
    • Factor IX
    • Metairie, Louisiana
    • +1 more
    Nov 14, 2022

    Ondexxya for Intravenous Injection 200mg Drug Use Result

    Recruiting
    • Life Threatening Bleeding
    • Factor Xa Inhibitor
      • Tokyo, Japan
        Research Site
      Jul 7, 2022

      Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))

      Completed
      Has Results
      • Hemophilia A With Inhibitors
      • Hemophilia B With Inhibitors
      • Coagulation FVIIa (Recombinant)
      • Aurora, Colorado
      • +8 more
      Feb 24, 2022

      SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Type

      Terminated
      • Type2 Diabetes
      • Cognitive Impairment
      • MOCA cognitive evaluation test
      • +3 more
      • Istanbul, Turkey
        Istanbul Medeniyet University Goztepe Research and Training Hosp
      Apr 16, 2022